SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Nov 7, 2024
Document Date
Sep 30, 2024
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Akebia Therapeutics
Issuer
Akebia Therapeutics, Inc.
XBRL
Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet
Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142
+1 617.871.2098 phone
+1 617.871.2099 fax